![](/img/cover-not-exists.png)
Phase 1 trial of vorolanib (CM082) in combination with everolimus in patients with advanced clear-cell renal cell carcinoma
Sheng, Xinan, Yan, Xieqiao, Chi, Zhihong, Cui, Chuanliang, Si, Lu, Tang, Bixia, Li, Siming, Mao, Lili, Lian, Bin, Wang, Xuan, Bai, Xue, Zhou, Li, Kong, Yan, Dai, Jie, Ding, Lieming, Mao, Li, Guo, JunVolume:
55
Journal:
EBioMedicine
DOI:
10.1016/j.ebiom.2020.102755
Date:
May, 2020
File:
PDF, 1.19 MB
2020